New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2

Genes and Development

Volumn 12, Issue 13, 1998, Pages 2073-2090

  Botquin, Valérie ^a   Hess, Heike ^d   Fuhrmann, Guy ^b   Anastassiadis, Constantinos ^a   Gross, Michael K ^c   Vriend, Gerrit ^a   Schöler, Hans R ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b CNRS   (France)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d NONE

Author keywords

Oct; Osteopontin; POU; Preimplantation embryo; Sox

Indexed keywords

HOMEODOMAIN PROTEIN; INTEGRIN; OSTEOPONTIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CHROMATIN; CONTROLLED STUDY; DNA BINDING; EMBRYO; ENHANCER REGION; IMMUNOPRECIPITATION; INTRON; MOUSE; NONHUMAN; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; STEM CELL; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0032128171     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.13.2073     Document Type: Article

References (71)

1. Adamson, E.D. 1986. Cell-lineage-specific gene expression in development. In Experimental approaches to mammalian embryonic development (ed. J. Rossant and R.A. Pederson), pp. 321-364. Cambridge University Press, Cambridge, UK.
2. Ambrosetti, D.C., C. Basilico, and L. Dailey. 1997. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell Biol. 17: 6321-6329.
3. Behrendtsen, O., CM. Alexander, and Z. Werb. 1995. Cooperative interactions between extracellular matrix, integrins and parathyroid hormone-related peptide regulate parietal endoderm differentiation in mouse embryos. Development 121: 4137-4148.
4. Caelles, C., H. Hennemann, and M. Karin. 1995. M-phase-specific phosphorylation of the POU transcription factor GHF-1 by a cell cycle-regulated protein kinase inhibits DNA binding. Mol. Cell. Biol. 15: 6694-6701.
5. Chinea, G., G. Padron, R.W. Hooft, C. Sander, and G. Vriend. 1995. The use of position-specific rotamers in model building by homology. Proteins 23: 415-421.
6. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal. Biochem. 162: 156-159.
7. Collignon, J., S. Sockanathan, A. Hacker, M. Cohen-Tannoudji, D. Norris, S. Rastan, M. Stevanovic, P.N. Goodfellow, and R. Lovell-Badge. 1996. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 122: 509-520.
8. Curatola, A.M. and C. Basilico. 1990. Expression of the K-fgf proto-oncogene is controlled by 3′ regulatory elements which are specific for embryonal carcinoma cells. Mol. Cell. Biol. 10: 2475-2484.
9. Dailey, L., H. Yuan, and C. Basilico. 1994. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol. Cell. Biol. 14: 7758-7769.
10. Denhardt, D.T. and X. Guo. 1993. Osteopontin: A protein with diverse functions. FASEB J. 7: 1475-1482.
11. Denhardt, D.T., W.T. Butler, A.F. Chambers, and D.R. Senger. 1995. Gene expression and phosphorylation of mouse osteopontin. In Osteopontin: Role in cell signaling and adhesion (ed. D.T. Denhardt, W.T. Butler, A.F. Chambers, and D.R. Senger). The New York Academy of Sciences, New York, NY.
12. Eble, J.A. and K. Kühn. 1997. In Integrin-ligand interaction (ed. J.A. Eble and K. Kühn). Springer-Verlag, Heidelberg, Germany.
13. Fässler, R. and M. Meyer. 1995. Consequences of lack of β1 integrin gene expression in mice. Genes & Dev. 9: 1896-1908.
14. Feldman, B., W. Poueymirou, V.E. Papaioannou, T.M. DeChiara, and M. Goldfarb. 1995. Requirement of FGF-4 for postimplantation mouse development. Science 267: 246-249.
15. Ferrari, S., V.R. Harley, A. Pontiggia, P.N. Goodfellow, R. Lovell-Badge, and M.E. Bianchi. 1992. SRY, like HMG 1, recognizes sharp angles in DNA. EMBO J. 11: 4497-4506.
16. Fujii, H. and H. Hamada. 1993. A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages. Neuron 11: 1197-1206.
17. Gardner, R.L. 1983. Origin and differentiation of extraembryonic tissues in the mouse. Int. Rev. Exp. Pathol. 24: 63-133.
18. Giese, K., J. Cox, and R. Grosscheld. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185-195.
19. Herr, W. and M.A. Cleary. 1995. The POU domain: Versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes & Dev. 9: 1679-1693.
20. Hogan, B.L.M., A. Taylor, and E. Adamson. 1981. Cell interactions modulate embryonal carcinoma cell differentiation into parietal and visceral endoderm. Nature 291: 235-237.
21. Hogan, B.L.M., R. Beddington, F. Constantini, and E. Lacy. 1994. Section I: In vitro culture of eggs, embryos, primordial sperm cells and teratocarcinoma cells. In Manipulating the mouse embryo. A laboratory manual (ed. B.L.M. Hogan, R. Beddington, F. Constantini, and E. Lacy), 2nd ed., p. 386. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Hynes, R.O. 1996. Targetes mutations in cell adhesion genes: What have we learned from them? Dev. Biol. 180: 402-412.
23. Jacobson, E.M., P. Li, A. Leon-del-Rio, M.G. Rosenfeld, and A.K. Aggarwal. 1997. Structure of Pit-1 POU domain bound to DNA as a dimer: Unexpected arrangement and flexibility. Genes & Dev. 11: 198-212.
24. Kapiloff, M.S., Y. Farkash, M. Wegner, and M.G. Rosenfeld. 1991. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253: 786-789.
25. Klemm, J.D. and C.O. Pabo. 1996. Oct-1 POU domain-DNA interactions: Cooperative binding of isolated subdomains and effects of covalent linkage. Genes & Dev. 10: 27-36.
26. Klemm, J.D., M.A. Rould, R. Aurora, W. Herr, and C.O. Pabo. 1994. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77: 21-32.
27. Kraft, H.J., S. Mosselman, H.A. Smits, P. Hohenstein, E. Piek, Q. Chen, K. Artzt, and E.J. van Zoelen. 1996. Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. J. Biol. Chem. 271: 12873-12878.
28. Kroczek, R.A. 1993. Southern and Northern analysis. J. Chromatogr. 618: 133-145.
29. Leger, H., E. Sock, K. Renner, F. Grummt, and M. Wegner. 1995. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y. Mol. Cell. Biol. 15: 3738-3747.
30. Liu, L. and R.M. Roberts. 1996. Silencing of the gene for the beta subunit of human gonadotropin by the embryonic transcription factor Oct 3/4. J. Biol. Chem. 271: 16683-16689.
31. MacPhee, D.J., K.J. Barr, P.A. De Sousa, S.D. Todd, and G.M. Kidder. 1994. Regulation of Na+, K(+)-ATPase alpha subunit gene expression during mouse preimplantation development. Dev. Biol. 162: 259-266.
32. Nadijcka, M. and N. Hillman. 1974. Ultrastructural studies of the mouse blastocyst substages. J. Embryol. Exp. Morphol. 32: 675-695.
33. Niswander, L. and G.R. Martin. 1992. Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 114: 755-768.
34. Nomura, S., A.J. Wills, D.R. Edwards, J.K. Heath, and B.L. Hogan. 1988. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell. Biol. 106: 441-450.
35. Okamoto, K., H. Okazawa, A. Okuda, M. Sakai, M. Muramatsu, and H. Hamada. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60: 461-472.
36. Orlando, V. and R. Paro. 1993. Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin. Cell 75: 1187-1198.
37. Palmieri, S.L., W. Peter, H. Hess, and H.R. Schöler. 1994. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 166: 259-267.
38. Pesce, M., X. Wang, D.J. Wolgemuth, and H.R. Schöler. 1998a. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech. Dev. 71: 89-98.
39. Pesce, M., M.K. Gross, and H.R. Schöler. 1998b. In line with our ancestors: Oct-4 and the mammalian germ. BioEssays (in press).
40. Pruitt, S.C. 1994. Primitive streak mesoderm-like cell lines expressing Pax-3 and Hox gene autoinducing activities. Development 120: 37-47.
41. Rizzino, A. and E. Rosfjord. 1994. Transcriptional regulation of the murine k-fgf gene. Mol. Reprod. Dev. 39: 106-111.
42. Robertson, E. 1987. Cell culture methods and induction of differentiation of embryonal carcinoma. In Teratocarcinomas and embryonic stem cells. A practical approach, pp. 19-50. IRL Press, Oxford, UK.
43. Rosen, B. and R.S. Beddington. 1993. Whole-mount in situ hybridization in the mouse embryo: Gene expression in three dimensions. Trends Genet. 9: 162-167.
44. Rosfjord, E. and A. Rizzino. 1994. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells. Biochem. Biophys. Res. Commun. 203: 1795-1802.
45. Rosner, M.H., M.A. Vigano, K. Ozato, P.M. Timmons, F. Poirier, P.W. Rigby, and L.M. Staudt. 1990. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345: 686-692.
46. Ryan, A.K. and M.G. Rosenfeld. 1997. POU domain family values: Flexibility, partnerships, and developmental codes. Genes & Dev. 11: 1207-1225.
47. Saijoh, Y., H. Fujii, C. Meno, M. Sato, Y. Hirota, S. Nagamatsu, M. Ikeda, and H. Hamada. 1996. Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor. Genes Cells 1: 239-252.
48. Schöler, H.R. 1991. Octamania: The POU factors in murine development. Trends Genet. 7: 323-329.
49. Schöler, H.R., R. Balling, A.K. Hatzopoulos, N. Suzuki, and P. Gruss. 1989a. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J. 8: 2551-2557.
50. Schöler, H.R., A.K. Hatzopoulos, R. Balling, N. Suzuki, and P. Gruss. 1989b. A family of octamer-specific proteins present during mouse embryogenesis: Evidence for germline-specific expression of an Oct factor. EMBO J. 8: 2543-2550.
51. Schöler, H.R., G.R. Dressler, R. Balling, H. Rohdewohld, and P. Gruss. 1990a. Oct-4: A germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9: 2185-2195.
52. Schöler, H.R., S. Ruppert, N. Suzuki, K. Chowdhury, and P. Gruss. 1990b. New type of POU domain in germ line-specific protein Oct-4. Nature 344: 435-439.
53. Schöler, H.R., T. Ciesiolka, and P. Gruss. 1991. A nexus between Oct-4 and E1A: Implications for gene regulation in embryonic stem cells. Cell 66: 291-304.
54. Schoorlemmer, J. and W. Kruijer. 1991. Octamer-dependant regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells. Mech. Dev. 36: 75-86.
55. Segil, N., S.B. Roberts, and N. Heintz. 1991. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 254: 1814-1816.
56. Solomon, M.J., P.L. Larsen, and A. Varshavsky. 1988. Mapping protein-DNA interactions in vivo with formaldehyde: Evidence that histone H4 is retained on a highly transcribed gene. Cell 53: 937-947.
57. Stephens, L.E., A.E. Sutherland, I.V. Klimanskaya, A. Andrieux, J. Meneses, R.A. Pedersen, and C.H. Damsky. 1995. Deletion of β1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes & Dev. 9: 1883-1895.
58. Stickland, S. and V. Mahdavi. 1978. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393-404.
59. Strickland, S., K.K. Smith, and K.R. Marotti. 1980. Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21: 347-355.
60. Sylvester, I. and H.R. Schöler. 1994. Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res. 22: 901-911.
61. Verrijzer, C.P. and P.C. van der Vliet. 1993. POU domain transcription factors. Biochim. Biophys. Acta 1173: 1-21.
62. Verrijzer, C.P., J.A. van Oosterhout, W.W. van Weperen, and P.C. van der Vliet. 1991. POU proteins bend DNA via the POU-specific domain. EMBO J. 10: 3007-3014.
63. Vriend, G. 1990. WHAT IF: A molecular modeling and drug design program. J. Mol. Graph. 8: 52-56.
64. Vriend, G. and V. Eijsink. 1993. Prediction and analysis of structure, stability and unfolding of thermolysin-like proteases. J. Comput. Aided Mol. Des. 7: 367-396.
65. Waterhouse, P., R.S. Parhar, X. Guo, P.K. Lala, and D.T. Denhardt. 1992. Regulated temporal and spatial expression of the calcium-binding proteins calcyclin and OPN (osteopontin) in mouse tissues during pregnancy. Mol. Reprod. Dev. 32: 315-323.
66. Wegner, M., D.W. Drolet, and M.G. Rosenfeld. 1993. POU-domain proteins: Structure and function of developmental regulators. Curr. Opin. Cell Biol. 5: 488-498.
67. Werner, M.H., J.R. Huth, A.M. Gronenborn, and G.M. Clore. 1995. Molecular basis of human 46X, Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81: 705-714.
68. Yeom, Y.I., H.-S. Ha, R. Balling, H.R. Schöler, and K. Artzt. 1991. Structure, expression and chromosomal location of the Oct-4 gene. Mech. Dev. 35: 171-179.
69. Yeom, Y.I., G. Fuhrmann, C.E. Ovitt, A. Brehm, K. Ohbo, M. Gross, K. Hübner, and H.R. Schöler. 1996. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122: 881-894.
70. Yuan, H., N. Corbi, C. Basilico, and L. Dailey. 1995. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox-2 and Oct-3. Genes & Dev. 9: 2635-2645.
71. Zwilling, S., H. Konig, and T. Wirth. 1995. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14: 1198-1208.